Dolasetron Mesylate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

5 API Suppliers, 4 USDMF, 1 EU WC, 3 NDC API, 2 Listed Suppliers, $ API Reference Price

FINISHED DOSAGE FORMULATIONS

7 FDF Dossiers, 5 FDA Orange Book, 1 South Africa, 1 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG, TABLET;ORAL - 50MG, INJECTABLE;INJECTION - 100MG/5ML (20MG/ML), INJECTABLE;INJECTION - 12.5MG/0.625ML (20MG/ML)

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 3 DKSH, 2 Jai Radhe Sales, 4 Faran Shimi Pharmaceutical, 7 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 ACG Worldwide, 5 Actylis, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 13 BASF, 10 Corel Pharma Chem, 1 DFE Pharma, 2 Finar, 8 Gangwal Chemicals, 4 Ideal Cures Pvt Ltd, 4 Ingredion Pharma Solutions, 15 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 8 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Novo Excipients, 4 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 11 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

43 Coating Systems & Additives, 41 Fillers, Diluents & Binders, 23 Direct Compression, 21 Controlled & Modified Release, 17 Solubilizers, 17 Disintegrants & Superdisintegrants, 14 Chewable & Orodispersible Aids, 14 Taste Masking, 13 Topical, 12 Thickeners and Stabilizers, 12 Parenteral, 12 Co-Processed Excipients, 11 Film Formers & Plasticizers, 11 Granulation, 8 Lubricants & Glidants, 6 Emulsifying Agents, 5 Empty Capsules, 5 API Stability Enhancers, 5 Coloring Agents, 4 Vegetarian Capsules, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents